Meiqi Wang

3PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 24, 2025
Eribulin plus Pyrotinib in Trastuzumab-Resistant, HER2-Positive Advanced Breast Cancer: A Single-Arm, Multicenter Phase II Trial (EPIC Trial).

Ruoyang Li, Meiqi Wang, Xiangshun Kong

|Feb 28, 2024
Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity.

Bin Xu, Liu Yang, Lixian Yang

|Jun 16, 2023
Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer.

Bozhao Li, Feilong Qi, Fei Zhu

Pageof 1

Frequent Collaborators

3 joint publications

Zhenchuan Song

1 joint publications

Bozhao Li

1 joint publications

Feilong Qi

1 joint publications

Fei Zhu

1 joint publications

Zefang Lu

1 joint publications

Tianjiao Chu

1 joint publications

Suying Wu

1 joint publications

Jingyan Wei

1 joint publications

Saraswati Sukumar

1 joint publications

Cheng Zhang

Frequent Collaborators

3 joint publications

Zhenchuan Song

1 joint publications

Bozhao Li

1 joint publications

Feilong Qi

1 joint publications

Fei Zhu

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.6K
Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

8.7K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on : Oct 05, 2017

11.0K
See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

7.6K
Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

8.7K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on : Oct 05, 2017

11.0K
See more related videos